MM

Mark Marchionni

AT Acorda Therapeutics: 16 patents #3 of 56Top 6%
CN Cambridge Neuroscience: 5 patents #17 of 40Top 45%
BC Beth Israel Deaconess Medical Center: 4 patents #72 of 672Top 15%
LR Ludwig Institute For Cancer Research: 4 patents #149 of 611Top 25%
BH Brigham and Women's Hospital: 4 patents #209 of 1,764Top 15%
📍 Arlington, MA: #135 of 2,056 inventorsTop 7%
🗺 Massachusetts: #4,370 of 88,656 inventorsTop 5%
Overall (All Time): #173,108 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
10717775 Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2 2020-07-21
10232016 Methods for treating congestive heart failure Ralph Kelly, Beverly Lorell, Douglas B. Sawyer 2019-03-19
10065999 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2 2018-09-04
8394761 Methods for treating congestive heart failure Ralph Kelly, Beverly Lorell, Douglas B. Sawyer 2013-03-12
8114838 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2 2012-02-14
8076283 Methods for treating congestive heart failure Ralph Kelly, Beverly Lorell, Douglas B. Sawyer 2011-12-13
8026213 Methods for treating muscle diseases and disorders Robert Sklar, David I. Gwynne 2011-09-27
7968678 Glial mitogenic factors, their preparation and use Andrew Goodearl, Paul Stroobant, Luisa Minghetti, Michael Waterfield, Maio Su Chen +1 more 2011-06-28
7718606 Methods for treating muscle diseases and disorders Robert Sklar, David I. Gwynne 2010-05-18
7662772 Methods for treating congestive heart failure Ralph Kelly, Beverly Lorell, Douglas B. Sawyer 2010-02-16
7384756 Methods for treating muscle diseases and disorders Robert Sklar, David I. Gwynne 2008-06-10
7319019 Glial mitogenic factors lacking an N-terminal signal sequence Andrew Goodearl, Paul Stroobant, Luisa Minghetti, Michael Waterfield, Maio Su Chen +1 more 2008-01-15
7115554 Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III Robert Sklar, David I. Gwynne 2006-10-03
7037888 Methods for treating muscle diseases and disorders Robert Sklar, David I. Gwynne 2006-05-02
6890751 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods 2005-05-10
6872698 Methods for treating neurological injuries and disorders Michael Jarpe, Ted Ebendal 2005-03-29
6750196 Methods of treating disorders of the eye Thomas A. Reh, Kathryn L. McCabe, Olivia M. Bermingham-McDonogh, Nagesh K. Mahanthappa, David I. Gwynne 2004-06-15
6635249 Methods for treating congestive heart failure Ralph Kelly, Beverly Lorell, Douglas B. Sawyer 2003-10-21
6444642 Methods of increasing myotube formation or survival or muscle cell mitogenesis, differentiation or survival using a neuregulin Robert Sklar, David I. Gwynne 2002-09-03
6232061 Homology cloning Carl D. Johnson 2001-05-15
6204241 Method for treating nervous system pathophysiologies using glial growth factors Andrew Goodearl, Paul Stroobant, Luisa Minghetti, Michael Waterfield, Maio Su Chen +1 more 2001-03-20
6087323 Use of neuregulins as modulators of cellular communication David I. Gwynne, Nagesh K. Mahanthappa, Olivia M. Bermingham-McDonogh, Stanley M. Goldin, Robert N. McBurney 2000-07-11
5876973 Method for making antibodies which specifically bind to glial growth factors 1999-03-02
5716930 Glial growth factors Andrew Goodearl, Paul Stroobant, Luisa Minghetti, Michael Waterfield, Maio Su Chen +1 more 1998-02-10